Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection
SENORITA2
1 other identifier
interventional
243
1 country
9
Brief Summary
Purpose: To prove the feasibility of sentinel node navigation surgery (SNNS) in early gastric cancer patients with the risk of lymph node metastasis after endoscopic resection and preparation of multicenter phase 3 trial of stomach preserving surgery in these patients. Contents: The number of enrollment is 247 patients. The patients underwent endoscopic resection for early gastric cancer, and the tumor was defined to be out of indication for endoscopic resection pathologically. So, additional gastrectomy is recommended for them. The investigators will enroll patients who agree this study. After general anesthesia, Tc99m-Phytate with indocyanine green will be injected with endoscopy. Then sentinel basin will be detected using gamma probe and laparoscopic basin dissection will be done. Sentinel lymph node will be identify in back table dissection, and patients will undergo conventional gastrectomy. Detection rate and false negative rate will be evaluated by pathological review.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2017
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 20, 2017
CompletedFirst Submitted
Initial submission to the registry
April 10, 2017
CompletedFirst Posted
Study publicly available on registry
April 21, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 21, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 2, 2025
March 1, 2025
7.7 years
April 10, 2017
March 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
detection rate (%)
number of patients whose sentinel nodes are detected / enrolled number of patients \*100
15 days after operation
Secondary Outcomes (1)
False negative rate
15 days after operation
Study Arms (1)
Sentinel basin dissection
EXPERIMENTALIntervention: Sentinel basin dissection
Interventions
Sentinel basin detection using endoscopic detector (Tc99m plus indocyanine green) injection and laparoscopic sentinel basin dissection. Then conventional gastrectomy
Eligibility Criteria
You may qualify if:
- No limitation for age if the patient is available for gastrectomy
- Patient who underwent endoscopic submucosal dissection and the tumor was defined as out of indication.
- The expanded criteria for endoscopic resection are as follows
- criterion I: intramucosal tumor without ulcerative findings and of differentiated type with size \> 2 cm
- criterion II: intramucosal tumor with ulcerative findings and of differentiated type with size ≤ 3 cm
- criterion III: intramucosal tumor without ulcerative findings and of undifferentiated type with size \< 2 cm
- criterion IV, submucosal invasion \< 500 mm and of differentiated type with size ≤ 3 cm)
- Eastern Cooperative Oncology Group (ECOG) performance scale 0 or 1
You may not qualify if:
- Inoperative due to severe cardiovascular or pulmonary disease
- Pregnant
- Patients who had previous gastric surgery
- Patients who had previous upper abdomen surgery except cholecystectomy, or radiation therapy on upper abdomen, or hypersensitivity to any medicine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Bang Wool Eom
Goyang-si, Gyeonggi-do, 10408, South Korea
Soonchunhyang University College of Medicine
Bucheon-si, South Korea
Dongnam Institute of Radiological and Medical Science
Busan, South Korea
Gyeongsang National University Changwon Hospital
Changwon, South Korea
Kyungpook National University Medical Center
Daegu, South Korea
Chonnam National University Hwasun Hospital
Hwasun, South Korea
Gyeongsang National University Hospital
Jinju, South Korea
Samsung Medical Center
Seoul, South Korea
Ajou University School of Medicine
Suwon, South Korea
Related Publications (1)
Eom BW, Yoon HM, Min JS, Cho I, Park JH, Jung MR, Hur H, Kim YW, Park YK, Nam BH, Ryu KW; Sentinel Node Oriented Tailored Approach (SENORITA) Study Group. Prospective Multicenter Feasibility Study of Laparoscopic Sentinel Basin Dissection after Endoscopic Submucosal Dissection for Early Gastric Cancer: SENORITA 2 Trial Protocol. J Gastric Cancer. 2019 Jun;19(2):157-164. doi: 10.5230/jgc.2019.19.e12. Epub 2019 Apr 15.
PMID: 31245160DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bang Wool Eom, MD, PhD
National Cancer Center, Korea
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff surgeon
Study Record Dates
First Submitted
April 10, 2017
First Posted
April 21, 2017
Study Start
March 20, 2017
Primary Completion
November 21, 2024
Study Completion
December 31, 2024
Last Updated
April 2, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share